EQS Equasens Société anonyme

EPA · FR · Healthcare · Health Information Services · equasens.com

29.50EUR0.00%Mkt Cap: 481.94M $P/E: 11.39Today

Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Servic…

Industry Peers

Health Information Services

Tempus AI, Inc. - Class A Common Stock

$13.83BUSD

BTSG

BrightSpring Health Services, Inc. - Common Stock

HealthEquity, Inc. - Common Stock

Waystar Holding Corp. - Common Stock

$4.76BUSDP/E 35.4

HTFL

Heartflow, Inc. - Common Stock

$4.29BUSD

PRVA

Privia Health Group, Inc. - Common Stock

$2.59BUSDP/E 92.3

SDGR

Schrodinger, Inc. - Common Stock

$2.27BUSD

OMCL

Omnicell, Inc. - Common Stock

$1.53BUSDP/E 40.0

CERT

Certara, Inc. - Common Stock

$1.43BUSD

OMDA

Omada Health, Inc. - Common Stock

$1.25BUSDP/E 30.4

GDRX

GoodRx Holdings, Inc. - Class A Common Stock

HealthStream, Inc. - Common Stock

$942.97MUSDP/E 42.8

SOPH

SOPHiA GENETICS SA - Ordinary Shares

Weave Communications, Inc.

$592.12MUSD

RAY-B

RaySearch Laboratories AB (publ)

$523.69MUSDP/E 29.5

Key Statistics

Company

Market Cap481.94M USD

Enterprise Value488.26M USD

Revenue (TTM)257.09M USD

Gross Profit176.72M USD

Net Income (TTM)42.75M USD

Revenue/Share15.73 EUR

Last Price29.50 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees1.5K

CountryFR

SectorHealthcare

IndustryHealth Information Services

ISINFR0012882389

Valuation

P/E (Trailing)11.39

P/E (Forward)8.97

PEG2.60

EV/EBITDA8.69

EV/Revenue1.90

P/S1.87

P/B1.76

EPS (TTM)2.59

EPS (Forward)3.29

52W Range

28.605% of range45.35

52W High45.35 EUR

52W Low28.60 EUR

Profitability

Gross Margin68.74%

Oper. Margin22.17%

EBITDA Margin21.85%

Profit Margin16.63%

ROE15.59%

ROA8.96%

Growth

Revenue Growth10.80%

Earnings Growth15.70%

Cash Flow & Leverage

Operating CF64.39M USD

CapEx (TTM)13.12M USD

FCF Margin9.34%

FCF Yield4.98%

Net Debt-5.45M USD

Net Debt/EBITDA-0.10

Balance Sheet

Debt/Equity0.24

Current Ratio1.44

Quick Ratio1.10

Book Value/Sh16.78 EUR

Cash/Share3.92 EUR

Dividends

Fwd Div Rate1.40 EUR

Trail. Div Rate1.40 EUR

Div. Yield4.75%

5Y Avg Yield1.87%

Payout Ratio48.26%

Ex-Div DateJul 1, 2026

Pay Date—

Splits

Last Split5:1

Split DateAug 5, 2015

Analyst Consensus

Rating1.3 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)54.67 EUR

Upside (mean)+85.3%

Target Range51.00 EUR – 63.70 EUR

51.00+85.3% to mean63.70

# Analysts4

Ownership

Shares Out.15.03M

Float15.00M

Insiders67.09%

Institutions12.47%

Technical

SMA 5032.45 (-9.1%)

SMA 20036.39 (-18.9%)

Beta0.56

S&P 52W Chg14.58%

Avg Vol (30d)29.93K

Avg Vol (10d)37.65K

Technical Indicators

RSI (14)40.3

MACD-0.6467

MACD Signal-0.6746

MACD Hist.+0.0279

BB Upper32.76 EUR

BB Middle30.76 EUR

BB Lower28.76 EUR

BB Width13.00%

ATR (14)1.127 EUR

Vol Ratio (20d)0.94x